Latest News for: prelude adc

Edit

Prelude Therapeutics Announces Closing of $50M Series C Financing

The Marshall News Messenger 24 Aug 2020
Prelude Therapeutics, a privately-held, clinical-stage precision oncology company, today announced that it has completed a $50 million Series C financing round led by Prelude’s two existing institutional investors, including OrbiMed Advisors LLC, and a new investor, Fidelity Management & Research Company LLC ... and ADC Therapeutics SA.
  • 1
×